According to a recent market study published by Growth Market Reports, titled, "Global Intermittent Pneumatic Compression (IPC) Devices Market” is segmented into by Types, Application, Distribution Channel and by Region: Size, Share, Trends and Opportunity Analysis, 2018-2028", the market was valued at USD 926.1 Mn in 2020 and is expected to grow at a healthy CAGR of 6.5% to reach USD 1,531.3 Mn market share by the year 2028. The intermittent pneumatic compression (IPC) devices market is anticipated to grow significantly during forecast period.

Intermittent pneumatic compression (IPC) devices are used to help prevent blood clots in the deep veins of the legs. The devices use cuffs around the legs that fill with air and squeeze your legs. In terms of applications, the global intermittent pneumatic compression (IPC) devices market is bifurcated into home use and hospital. In terms of value, the home use segment is anticipated to expand at a CAGR of 7.1%, during the forecast period, due to growing demand of lightweight and portable IPC devices.

On the basis of distribution channels, the market is segmented into clinics, pharmacies, other offline channels and online channels. The online channel segment is anticipated to expand at a CAGR of 7.7%, in terms of value, during the forecast period, due the increase in penetration of Internet and digitalization, and the convenience they provide to the end-users.

Request a free sample copy @

Based on regions, the global intermittent pneumatic compression (IPC) devices is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is a promising region for the market. In terms of value, the North America region constituted 37.4% share of the global market in 2020 and is projected to account for a major share of the market during the forecast period, due to increase in research and development activities in healthcare and medical technology sector. In terms of value, the market in Asia Pacific is projected to expand at a CAGR of 11.0% during the forecast period.

As per Growth Market Reports industry analyst Rajas Shirwalkar, “The intermittent pneumatic compression (IPC) devices market is anticipated to witness significant growth during forecast period 2020-2028. Medical devices manufacturing was hampered across countries due to the outbreak of COVID-19. However, due to home isolation and decrease in outdoor mobility many people developed vascular clot diseases, which in turn, increased the demand and use of IPC devices during pandemic. The key players are engaged in advertising their products through offline channels such as hospitals and pharmacies and online social media platforms including Instagram, Facebook, and Twitter.”

The first quarter of 2020 was an unforeseen turning point for the medical device and healthcare market. Supply chains were disturbed by COVID-19 outbreaks in major regions, but demand for various medical products including IPC devices were increased, due to health crisis across the globe. Certain discrepancies in production and supply chain created mild disruptions across some areas in the supply chain of the intermittent pneumatic compression (IPC) devices market.

However, after second quadrant due to increasing product demand for home-use IPC devices has boosted market growth in 2020. Increasing production process owing to government regulation and rising concern for health safety in multiple organizations boosted the use of intermittent pneumatic compression (IPC) devices in 2020.

Key Takeaways from the Study

  • The market in North America is projected to expand at a significant CAGR during the forecast period, owing to the presence of several local market participants and increasing healthcare infrastructure in the region. The market in Asia Pacific is anticipated to hold a substantial share of the global intermittent pneumatic compression (IPC) device market, owing to the well-developed medtech in the region and presence of established market participants.
  • The pulmonary embolism (PE) segment is expected to expand at significant growth rate, as it is a condition where blood clots migrate along with the flow from various parts of body to lungs and blocks blood vessels of the lungs. PE has the potential to damage the part of the lung due to restricted blood flow, and decrease blood oxygen concentration. If left untreated, it can cut off the flow of blood to the lungs. Pneumatic compression treatment uses calf-high or thigh-high cuffs that alternatively inflate with air and deflate every few minutes automatically to squeeze and massage the veins in legs and ameliorate blood flow. Hence, IPC devices are used in prophylaxis of PE to avoid permanent lung damage.

Report Scope

Report Metric


Market Value in 2020

USD 926.1 Mn

Market Growth Rate (from 2021 to 2028)


Historical Data

2018 & 2019

Base Year


Forecast Period

2021 – 2028

Market Segments

By Type, By Application, and By Distribution Channel

Regional Scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

Country Scope

U.S., Canada, Germany, France, Italy, U.K., Spain, Russia, Rest of Europe, China, Japan, South Korea, India, Taiwan, SEA, and rest of APAC. Brazil, Mexico, Rest of Latin America, Saudi Arabia, South Africa, UAE and Rest of MEA.

Key Companies Profiled

Arjo Huntleigh, Bio Compression Systems, Cardinal Health, Currie Medical Specialties, Devon Medical Products, DJO Global, Medline, Mego Afek ltd., ThermoTek, Zimmer Biomet, Breg Inc., ManaMed Inc., Encompass Group, LLC

Customization Scope

Report customization available on request

Target Audience

  • Supply-side: Manufacturers, raw material suppliers, and distributors
  • Demand Side: Hospitals, Individuals
  • Regulatory Side: Concerned government authorities, and other regulatory bodies.